Literature DB >> 1702403

Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant.

A Oppenheim1, A Yaari, D Rund, E A Rachmilewitz, D Nathan, C Wong, H H Kazazian, B Miller.   

Abstract

The mechanism for elevated production of fetal hemoglobin (Hb F) in a Druze patient with beta zero-thalassemia intermedia was investigated. Heterozygous family members exhibited normal Hb F levels, suggesting that the increase in gamma-gene expression in the propositus may be partly due to anemic stress. Erythroid progenitors of these family members cultured in vitro [burst forming units (erythroid); (BFUe)] showed elevated synthesis of Hb F, indicating the existence of a genetically determined intrinsic capacity for high Hb F production in this family. The propositus was found to be homozygous for a IVS2-position 1 mutation, on the background of Mediterranean haplotype I, which is not known to be linked to high Hb F production. Moreover, extensive molecular studies of the beta-globin gene cluster, including sequence analysis of the promoter regions of the gamma-globin genes, did not reveal any cis- actin mechanism that could account for the high Hb F production in the propositus. A young niece of the propositus with beta zero-thalassemia major was recently discovered, who was homozygous for the same beta-globin allele and haplotype as the propositus. However, unlike her uncle, she does not have a high Hb F level and presents with a severe clinical course. Her inability to produce high Hb F suggests that the genetic determinant for increased gamma-gene expression in the propositus is unlinked to the beta-globin gene cluster.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702403     DOI: 10.1007/bf00197701

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Association of thalassaemia intermedia with a beta-globin gene haplotype.

Authors:  S L Thein; J S Wainscoat; M Sampietro; J M Old; D Cappellini; G Fiorelli; B Modell; D J Weatherall
Journal:  Br J Haematol       Date:  1987-03       Impact factor: 6.998

2.  A genetic marker for elevated levels of haemoglobin F in homozygous sickle cell disease?

Authors:  J S Wainscoat; S L Thein; D R Higgs; J I Bell; D J Weatherall; B H Al-Awamy; G R Serjeant
Journal:  Br J Haematol       Date:  1985-06       Impact factor: 6.998

3.  Association of the level of G gamma chain in the fetal hemoglobin of normal adults with specific haplotypes.

Authors:  Y Hattori; F Kutlar; C J Mosley; S M Mayson; T H Huisman
Journal:  Hemoglobin       Date:  1986       Impact factor: 0.849

4.  Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.

Authors:  D Labie; J Pagnier; C Lapoumeroulie; F Rouabhi; O Dunda-Belkhodja; P Chardin; C Beldjord; H Wajcman; M E Fabry; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

5.  Two independent genetic factors in the beta-globin gene cluster are associated with high G gamma-levels in the HbF of SS patients.

Authors:  J G Gilman; T H Huisman
Journal:  Blood       Date:  1984-08       Impact factor: 22.113

6.  Linkage of beta-thalassaemia mutations and beta-globin gene polymorphisms with DNA polymorphisms in human beta-globin gene cluster.

Authors:  S H Orkin; H H Kazazian; S E Antonarakis; S C Goff; C D Boehm; J P Sexton; P G Waber; P J Giardina
Journal:  Nature       Date:  1982-04-15       Impact factor: 49.962

7.  Quantification of the close association between DNA haplotypes and specific beta-thalassaemia mutations in Mediterraneans.

Authors:  H H Kazazian; S H Orkin; A F Markham; C R Chapman; H Youssoufian; P G Waber
Journal:  Nature       Date:  1984 Jul 12-18       Impact factor: 49.962

8.  Radio-ligand immunoassay for human hemoglobin variants.

Authors:  J Javid; P K Pettis; J E Miller
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

9.  Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype.

Authors:  S H Embury; J A Miller; A M Dozy; Y W Kan; V Chan; D Todd
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

10.  Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia.

Authors:  B A Miller; N Olivieri; M Salameh; M Ahmed; G Antognetti; T H Huisman; D G Nathan; S H Orkin
Journal:  N Engl J Med       Date:  1987-01-29       Impact factor: 91.245

View more
  3 in total

1.  Beta-thalassemia major resulting from a compound heterozygosity for the beta-globin gene mutation: further evidence for multiple origin and migration of the thalassemia gene.

Authors:  Y Chifu; H Nakashima; H Hara; E Yokota; T Imamura
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

2.  The G1021A substitution in the RYR1 gene does not cosegregate with malignant hyperthermia susceptibility in a British pedigree.

Authors:  A M Adeokun; S P West; F R Ellis; P J Halsall; P M Hopkins; A M Foroughmand; D E Iles; R L Robinson; A D Stewart; J L Curran
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1.

Authors:  E R Bacon; N Dalyot; D Filon; L Schreiber; E A Rachmilewitz; A Oppenheim
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.